Healthcare >> Analyst Interviews >> September 24, 2007

BIOTECHNOLOGY & SPECIALTY PHARMACEUTICALS – DING DING – MAXIM GROUP, LLC

TWST: Let's start with an overview of your coverage.

Ms. Ding: Our coverage universe is currently structured around therapeutic

indications. We have 10 names under coverage right now over